Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Clinical Implications for Chronic Therapy As GLP-1 receptor agonists become a cornerstone of diabetes management, clinicians must adapt their monitoring strategies
A clean-label patch offers a low-commitment trial before pursuing care
LifeMD prescriptions are an additional cost to its membership
The SELECT trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) by 20% in adults with overweight or obesity and established heart disease (Lincoff et al., SELECT trial, New England Journal of Medicine , 2023)
Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
US$ 24.71
US$ 28.89
US$ 24.71
US$ 22.75
US$ 20.83
US$ 29.20
US$ 29.20
US$ 20.53
